Browse
Submit Data
Databases
API
Help

Dataset Information

0 Views

0 Connections

0 Citations

0 Reanalyses

0 Downloads

Omics score: 0

ABSTRACT: Viral communities of Shark Bay modern stromatolites

PROVIDER: PRJNA471212 | ENA |

REPOSITORIES: ENA

ACCESS DATA

Json Xml

Dataset's files

Source:

			Action	DRS
	SRR7160500.fastq.gz	Fastqsanger.gz

Items per page:

1 - 1 of 1

Similar Datasets

stromatolite metagenome

Project description:Comparative metagenomics of the stromatolites from Hamelin Pool, Shark Bay, Western Australia

| PRJNA429237 | ENA

Stromatolite Metagenome

Project description:Microbial and viral communities from stromatolites

| PRJNA28843 | ENA

Shark Bay Transcriptomics

Project description:Shark Bay Transcriptomics Transcriptome

| PRJNA628560 | ENA

Towards functional profiling for eDNA based monitoring in coastal environments: a comparison of three approaches

Project description:Monitoring microbial communities can aid in understanding the state of these habitats. Environmental DNA (eDNA) techniques provide efficient and comprehensive monitoring by capturing broader diversity. Besides structural profiling, eDNA methods allow the study of functional profiles, encompassing the genes within the microbial community. In this study, three methodologies were compared for functional profiling of microbial communities in estuarine and coastal sites in the Bay of Biscay. The methodologies included inference from 16S metabarcoding data using Tax4Fun, GeoChip microarrays, and shotgun metagenomics.

2024-04-14 | E-MTAB-13075 | biostudies-arrayexpress

Dual antiviral and anti-inflammatory effects of BAY 11-7082 in SARS-CoV-2 infection via inhibition of the canonical NF-κB signaling pathway_[supplementary Fig.1]

Project description:The continued emergence of SARS-CoV-2 variants and persistent inflammatory complications of COVID-19 highlight the urgent need for therapeutics with both antiviral and anti-inflammatory properties. Despite intensive global efforts, no approved antiviral therapy with these dual functions has yet been developed, representing a significant gap in current COVID-19 treatment strategies. In this study, we identify BAY 11-7082 (BAY) as a dual–action compound that inhibits SARS-CoV-2 replication and the production of virus-induced proinflammatory cytokines and chemokines, including IL-6, IL-8, CXCL1, and CXCL2. BAY predominantly exerts its antiviral activity at the post-entry stage of the viral life cycle. Mechanistically, BAY potentially interacts with SARS-CoV-2 NSP14 and inhibits virus-induced phosphorylation and degradation of IκBα, suppressing NF-κB activation through the IKK-IκBα signaling axis. Furthermore, BAY exhibits potent antiviral activity against multiple SARS-CoV-2 variants of concern (VOCs). Collectively, these findings support the potential of BAY as a dual-action therapeutic candidate, combining antiviral and anti-inflammatory effects, against SARS-CoV-2 and its emerging variants.

2026-04-03 | GSE310278 | GEO

Dual antiviral and anti-inflammatory effects of BAY 11-7082 in SARS-CoV-2 infection via inhibition of the canonical NF-κB signaling pathway

2026-04-03 | GSE310111 | GEO

MAGs from Shark Bay datasets

Project description:MAGs from Shark Bay datasets Metagenomic assembly

| PRJNA1160197 | ENA

microbial mat metagenome

Project description:Metagenomics of smooth mats in Shark Bay

| PRJNA505383 | ENA

stromatolite metagenome

Project description:Stromatolites Metagenome

| PRJNA275533 | ENA